Maltotriose Conjugated Metal-Organic Frameworks for Selective Targeting and Photodynamic Therapy of Triple Negative Breast Cancer Cells and Tumor Associated Macrophages
Overview
Authors
Affiliations
Herein, we report a nano-MOF conjugated to maltotriose as a new DDS. MA-PCN-224-0.1Mn/0.9Zn showed its ability to target cancer and TAM. This novel MOF is an effective PDT agent and shows little dark toxicity, MA-PCN-224-0.1Mn/0.9Zn uptakes selectively into cancer cells. A well-suited size control methodology was used so that the nano-scaled MOFs may take advantage of the EPR effect. This development of a nano-scale MOF for PDT that is conjugated to a cancer targeting ligand represents a meaningful development for the use of MOFs as drug delivery systems.
Multifunctional nanostructures: Intelligent design to overcome biological barriers.
Azizi M, Jahanban-Esfahlan R, Samadian H, Hamidi M, Seidi K, Dolatshahi-Pirouz A Mater Today Bio. 2023; 20:100672.
PMID: 37273793 PMC: 10232915. DOI: 10.1016/j.mtbio.2023.100672.
Zhan C, Jin Y, Xu X, Shao J, Jin C Cancer Med. 2023; 12(10):11049-11072.
PMID: 36794651 PMC: 10242868. DOI: 10.1002/cam4.5489.
Current Photoactive Molecules for Targeted Therapy of Triple-Negative Breast Cancer.
Dias C, Helguero L, Faustino M Molecules. 2021; 26(24).
PMID: 34946732 PMC: 8709347. DOI: 10.3390/molecules26247654.
Sakamaki Y, Ozdemir J, Heidrick Z, Azzun A, Watson O, Tsuji M ACS Appl Bio Mater. 2021; 4(2):1432-1440.
PMID: 34337346 PMC: 8320713. DOI: 10.1021/acsabm.0c01324.